No better way to celebrate #WorldIPDay than by celebrating Colombia's bold move to prioritize lives over ViiV Healthcare's monopoly. Superior treatment options won't be priced out of reach of Colombians w #HIV anymore!

It's what real eadership on pandemic response looks like. Viva 🇨🇴!

'With this decision, the Colombian government estimates that it will be able to put 28 people on dolutegravir for the same price that it is allocated today to treat just one person.'

हम माफ़ी माँगते हैं।
किसलिए?
बस एक-दो ग़लतियों के लिए।
कौनसी ग़लती?
बस उस दिन जो कह दिया था उसके लिए।
क्या कह दिया था?
अरे जो 22 नवम्बर को कहा था उसके लिए।
क्या कहा था 22 नवम्बर को?
अब जाने दो जो भी कहा था। बस माफ़ कर दो।

(How to write a smug non-apology.)

With 5.8 billion revenue and 1.1 billion net earnings in just 3 months in 2024, Danaher Corporation continues to impose a high financial and social cost on LMICs. Price reduction with #TimeFor5 is not only necessary but overdue as Danaher's moral debt to countries. #PeopleOverProfits

Danaher's President said today while releasing its 2024 quarterly earning: '... and believe we continued to gain market share in our molecular diagnostics business at Cepheid.' May be now is the time to drop the price for molecular GeneXpert test. #PeopleOverProfits Danaher Corporation

Worldwide Indonesia is #2 country with highest burden of tuberculosis (TB). But to treat patients, you have to diagnose them first. How can you do this if each GeneXpert test costs $15 to $20?

We need the price to drop. SIGN THE PETITION NOW: tinyurl.com/jn63nba5

#TimeFor5

My colleague Melissa Scharwey (she/her) Ärzte ohne Grenzen MSF Access Campaign spoke at the Subcommittee for Global Health Deutscher Bundestag about the necessity to include binding measures on transparency, equity and access to medical tools in the #PandemicTreaty World Health Organization (WHO)

Possible negative impact of changes made in Indian Patent Law indianexpress.com/article/opinio…

Superb call by nerdfighteria aka TBfighters for making revolutionary test GeneXpert at $5 for all diseases

This is such a crucial test. Congrats Danaher Corporation and Cepheid. Can you please also ensure that this test is available for $5 so infants everywhere who need this can access. Morbidity and mortality can be reduced in true sense only if its affordable! #TimeFor5